Bright Minds Biosciences Aktie
WKN DE: A2QN4Y / ISIN: CA10919W1086
|
17.11.2025 23:29:36
|
Why Bright Minds Biosciences Stock Topped the Market on Monday
Bright Minds Biosciences (NASDAQ: DRUG) is strengthening the team behind its latest investigational drug program, and investors expressed cautious optimism with the move. They pushed the clinical-stage biotech's shares up marginally (0.2%), on a Monday when the S&P 500 index dipped into the red with a 0.9% decrease. Less than two weeks after announcing the launch of a new program targeting the rare genetic disorder Prader-Willi Syndrome, Bright Minds said it's bringing in a quartet of seasoned experts to help with the effort. Image source: Getty Images.Continue readingWeiter zum vollständigen Artikel bei MotleyFool
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Bright Minds Biosciences Inc Registered Shs Reg S Accred Invmehr Nachrichten
| Keine Nachrichten verfügbar. |